Alternative strategies
Carmignac Portfolio Merger Arbitrage
Share Class
LU2585800878
Risk Indicator
2 / 7
Recommended Minimum Investment Horizon
3 years
Cumulative Performance since launch
Cumulative Performance 10 YearsCumulative Performance 5 YearsCumulative Performance 3 YearsCumulative Performance 12 Months
From 14/04/2023
To 06/05/2024
+ 3.7 %
-
-
-
+ 3.7 %
Calendar Year Performance 2014Calendar Year Performance 2015Calendar Year Performance 2016Calendar Year Performance 2017Calendar Year Performance 2018Calendar Year Performance 2019Calendar Year Performance 2020Calendar Year Performance 2021Calendar Year Performance 2022Calendar Year Performance 2023
-
-
-
-
-
-
-
-
-
+ 2.6 %
Net Asset Value
103.7 €
Asset Under Management
189 M €
Market
Global market
SFDR - Fund Classification
Article 8
Portfolio Composition
Discover the Fund's portfolio and allocation to get an overview of the distribution of its investments, to better understand its strategy, diversification and risk exposure.
Key figures
Below are the key figures for the Fund, which will give you a clearer idea of the Fund's management and equity positioning.Exposure Data
Data as of: 28 Mar 2024.Equity Investment Weight28.6 %
Net Equity Exposure19.5 %
Number of Equity Issuers35
Active Share50.0 %
TOP 10 Fund Positions
The main positions of Fund are classified according to their weighting and expressed as a percentage of the Fund's total assets.Top Ten - Equities
Data as of: 30 Apr 2024.| PIONEER NATURAL RESOURCES CO |  USA | Energy | 3.2% |
| HESS CORP | USA | Energy | 3.0% |
| LAWSON INC |  Japan | Consumer Staples | 1.6% |
| ENERPLUS CORP |  Canada | Energy | 1.5% |
| SHINKO ELECTRIC INDUSTRIES CO LTD | Japan | Information Technology | 1.3% |
| SOUTHWESTERN ENERGY CO | USA | Energy | 1.0% |
| NETWORK INTERNATIONAL HOLDINGS PLC |  United Arab Emirates | Financials | 0.9% |
| MORPHOSYS AG |  Germany | Healthcare | 0.9% |
| AXONICS INC | USA | Healthcare | 0.9% |
| CEREVEL THERAPEUTICS HOLDINGS INC | USA | Healthcare | 0.7% |
Total
15.0 %
Geographical Breakdown
The Fund’s exposure to specific country and region provides you with an insight on its diversification as well as the opportunities and risks involved. The geographic breakdown also provides an overview of the Fund's investment strategy and current positioning.Geographical Breakdown
Data as of: 30 Apr 2024.| North America | 6.9 % |
| Other countries | 5.1 % |
| Europe EUR | 3.0 % |
| Europe ex-EUR | 1.3 % |
| Total % of alternative | 16.2 % |
North America6.9 %
| USA | 4.9 % |
| Canada | 1.9 % |
Sector Breakdown
The Fund’s exposure to specific sector provides you with an insight on its diversification as well as the opportunities and risks involved. The sector breakdown also provides an overview of the Fund's investment strategy and current positioning.
Sector Breakdown
Data as of: 30 Apr 2024.Equity Exposure
The chart displays the proportion of the Fund's assets invested in equities and how this exposure has changed over time. It enables investors to understand the level of risk associated with the Fund and whether the asset allocation is in line with the Fund’s risk framework.Equity Exposure (% of total AUM)
Data as of: 30 Apr 2024.- Equity Investment Rate
- Equity Exposure
Equity Derivatives
This table lists all the equity derivatives in the portfolio. It shows the underlying assets to which the fund is exposed and the fund's position (long or short) on each of these underlyings.Equity Derivatives
Data as of: 3 May 2024.| Equity derivatives |
Total (Long + Short)
-7.8 %
Did you enjoy the fund page?
The reference to a ranking or prize, is no guarantee of the future results of the UCIS or the manager.
Carmignac Portfolio is a sub-fund of Carmignac Portfolio SICAV, an investment company under Luxembourg law, conforming to the UCITS Directive.
The information presented above is not contractually binding and does not constitute investment advice. Past performance is not a reliable indicator of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor), where applicable. Investors may lose some or all of their capital, as the capital in the UCI is not guaranteed. Access to the products and services presented herein may be restricted for some individuals or countries. Taxation depends on the situation of the individual. The risks, fees and recommended investment period for the UCI presented are detailed in the KIDs (key information documents) and prospectuses available on this website. The KID must be made available to the subscriber prior to purchase.). The reference to a ranking or prize, is no guarantee of the future results of the UCITS or the manager.